Surgery Partners (SGRY) Stock Price, News & Analysis

Company Overview

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Key Stats

• Today's Range: $22.54 to $22.85
• 50-Day Range: $20.20 to $23.84
• 52-Week Range: $18.87 to $33.90
• Volume: 1.13 million shs
• Average Volume: 1.68 million shs
• Market Capitalization: $2.91 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $33.00
• Consensus Rating: Moderate Buy

Surgery Partners Stock Analysis - MarketRank™

Surgery Partners scored higher than 59% of companies evaluated by MarketBeat, and ranked 446th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Surgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Surgery Partners has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 20.90%

Earnings Growth

Earnings for Surgery Partners are expected to grow by 20.90% in the coming year, from $0.67 to $0.81 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Surgery Partners is -15.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Surgery Partners is -15.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Surgery Partners has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.91% of the float of Surgery Partners has been sold short.

Short Interest Ratio / Days to Cover

Surgery Partners has a short interest ratio ("days to cover") of 7.6.

Change versus previous month

Short interest in Surgery Partners has recently increased by 8.27%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Surgery Partners does not currently pay a dividend.

Dividend Growth

Surgery Partners does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

16.91% of the float of Surgery Partners has been sold short.

Short Interest Ratio / Days to Cover

Surgery Partners has a short interest ratio ("days to cover") of 7.6.

Change versus previous month

Short interest in Surgery Partners has recently increased by 8.27%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 1.58

News Sentiment

Surgery Partners has a news sentiment score of 1.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Surgery Partners this week, compared to 5 articles on an average week.

MarketBeat Follows

Only 1 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $455,209.00 in company stock.

Percentage Held by Insiders

Only 2.70% of the stock of Surgery Partners is held by insiders.

SGRY Stock Analysis - Frequently Asked Questions

How have SGRY shares performed this year?

Surgery Partners' stock was trading at $21.17 at the beginning of 2025. Since then, SGRY shares have increased by 7.2% and is now trading at $22.69.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) issued its quarterly earnings results on Tuesday, August, 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.01. The company's quarterly revenue was up 8.4% compared to the same quarter last year.
Read the conference call transcript.

Who are Surgery Partners' major shareholders?

Surgery Partners' top institutional shareholders include King Street Capital Management L.P. (4.86%), Geode Capital Management LLC (1.50%), Invesco Ltd. (1.31%) and Glenview Capital Management LLC (1.19%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, David T Doherty, Jennifer Baldock, Wayne S Deveydt, Harrison R Bane, Bradley R Owens, Marissa Brittenham, William Trenton Webb, Brent Turner, Teresa Deluca, Laura L Brocklehurst and Danielle Burkhalter.
View institutional ownership trends.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

• Last Earnings: 8/05/2025
• Today: 8/30/2025
• Next Earnings (Estimated): 11/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:SGRY
• CIK: 1638833
• Web: www.surgerypartners.com
• Phone: (615) 234-5900
• Fax: 615-234-5998
• Employees: 15,000
• Year Founded: 2004

Price Target and Rating

• Average Price Target for Surgery Partners: $33.00
• High Price Target: $43.00
• Low Price Target: $24.00
• Potential Upside/Downside: +45.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 33.87
• P/E Growth: N/A
• Net Income: -$168.10 million
• Net Margins: -5.57%
• Pretax Margin: 3.97%
• Return on Equity: 2.51%
• Return on Assets: 1.01%

Debt

• Debt-to-Equity Ratio: 1.10
• Current Ratio: 1.93
• Quick Ratio: 1.78

Sales & Book Value

• Annual Sales: $3.11 billion
• Price / Sales: 0.93
• Cash Flow: $1.87 per share
• Price / Cash Flow: 12.11
• Book Value: $24.62 per share
• Price / Book: 0.92

Miscellaneous

• Outstanding Shares: 128,210,000
• Free Float: 124,747,000
• Market Cap: $2.91 billion
• Optionable: Optionable
• Beta: 1.82